Looking for Smart Healthcare Entrepreneurs !

Our members are very diverse in their background and that is reflected in our investments:

• 28% of our CEOs are women
• 23% of our CEOS are non-white

In addition to providing seed and early-stage funding, HealthTech Capital offers to a few selected entrepreneurs our virtual integrated Launchpad program or customized Mentoring.   We will discuss, during the Due Diligence process, any perceived risks or weakness you may be facing. Depending on mutual interest, we will discuss potential mentoring programs in addition to any direct investment to accelerate your progress.  

Monthly Cycle: Our selection committee looks at companies' submissions on our portal by the first Friday of every month.  Four companies are selected to present via web video, at our screening dinner on the third Tuesday of every month. Since Covid, we are doing all our meetings virtually until further notice.  In July 2022, we migrated to a new platform, powered by Dealum, to provide a better experience to entrepreneurs and help them syndicate with other investor groups.  Please note that confirmation emails  will come from dealum.com.

Free Process: We do NOT charge to apply or present... and have provided a light dinner!

No NDA: HealthTech Capital values its reputation. Although HTC treats company materials with respect, it makes no warranty and does not sign confidentiality agreements.

Feedback:  During the screening presentation, members record thoughts, questions, and perceptions. We summarize this information and provide you with feedback within a week. 

Due Diligence:  If the company generates sufficient investment interest, HealthTech capital will put together an investment team to execute its due diligence process.

 An ideal typical HealthTech Capital investment is a Company that:

• Can clearly articulate the pain point and unmet needs they are solving
• Has some validation on the product usability and benefits
• Has a road map on the business model: who pays and why?
• Has some metrics in customer acquisition and market channels
• Is seeking a seed or Series A investment
• Has no major FDA regulation approval process  (i.e no PMA or NDA)
• Is a US based Corporation

We understand that each Company and investment opportunity is unique!